Mechanisms of iron regulation and of iron deficiency
2007-06-08 - English

Screening hemochromatosis and iron overload
2007-06-08 - English

Recent advances in hemophilia management
2007-06-08 - English

The role of PET in staging and response assessment
2007-06-08 - English

Treatment of relapsing / refractory patients with Hodgkin's lymphoma
2007-06-08 - English

Genetics in CLL: Impact for prognosis and treatment decisions
2007-06-08 - English

New drugs for CLL
2007-06-08 - English

Targeting critical pathways in leukemic stem cells
2007-06-08 - English

Conventional and new treatment modalities in myelofibrosis
2007-06-08 - English

Conventional therapy of myelofibrosis is essentially palliative. It includes a wait-and-see approach for asymptomatic patients, oral cytolytic drugs such as hydroxyurea for the hyperproliferative forms of the disease, androgens or erythropoietin for the anemia, and...(more)

Human platelet alloantigens: heterogeneity of platelet alloantibodies
2007-06-08 - English

Laboratory diagnosis of neonatal alloimmune thrombocytopenia
2007-06-08 - English

Treatment and prevention of alloimmune thrombocytopenias
2007-06-08 - English

Pathology and genetics of T-cell lymphomas
2007-06-08 - English

Current treatment of T-cell lymphomas: are we making any progress?
2007-06-08 - English

Multiple myeloma: diagnosis, staging and criteria of response
2007-06-08 - English

Novel treatment approaches in multiple myeloma
2007-06-08 - English

High-dose melphalan followed by autologous stem cell transplantation in the younger patients and oral melphalan-prednisone in the elderly have been considered the standard of care for the initial therapy of myeloma. Survival after transplant appears to be related to the...(more)

Hemolysis-associated pulmonary hypertension in sickle cell disease and thalassemia
2007-06-08 - English

1. Understand the role of intravascular hemolysis in the development of impaired nitric oxide bioavailability.
2. Understand the contribution of impaired nitric oxide bioavailability to pulmonary hypertension in sickle cell disease and thalassemia.
3. Understand the...(more)

The contribution of asthma to sickle cell disease related morbidity and mortality
2007-06-08 - English

Hydroxyurea: benefits and risks in patients affected with sickle cell anemia
2007-06-08 - English

Genetics of T-cell acute lymphoblastic leukemia
2007-06-08 - English

Detection of minimal residual disease in adult patients with acute lymphoblastic leukemia: methodological advances and clinical significance
2007-06-08 - English

Molecular pathogenesis of myelodysplastic syndromes
2007-06-08 - English

New developments in curative approaches in myelodysplasia
2007-06-08 - English

The molecular and cellular basis for immunotherapeutic intervention in malignant disease: dynamic imaging of the immune system
2007-06-08 - English

The role of molecular analysis in the investigation of inherited anemias
2007-06-08 - English

Thrombophilia: from single gene disorder to complex disease
2007-06-08 - English

Venous thrombosis (VT) is an episodic disease. Blood clots are formed in veins which obstruct the circulation of the blood locally or, after the formation of emboli, elsewhere in the circulation. Acute events can be treated effectively by anticoagulant treatment aiming at...(more)

Primary allogeneic stem cell transplantation versus best available drug treatment in chronic myeloid leukemia
2007-06-09 - English

A molecular classification of leukaemia reveals MDS as a disease continuum with non-leukaemia and AML sub groups
2007-06-09 - English

A molecular classification of leukaemia reveals MDS as a disease continuum with non-leukaemia and AML sub groups.

Ken I. Mills1,2,7, Amanda F Gilkes1, Jesus M. Hernandez4,7, Wolf-Karsten Hofmann,5,, Alexander Kohlmann6, Mickey Williams6, Lothar Wieczorek6, Torsten...(more)